Low-dose radiation therapy for orbital lymphoma
Part of Cancer, Eyes & vision clinical trials.
This trial tests whether a short course of low-dose radiation (12 Gy in 6 sessions) is safe and effective for treating indolent (slow-growing) non-Hodgkin lymphoma in the eye socket (orbit). It may help control the disease while minimizing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed diagnosis of indolent (slow-growing) non-Hodgkin lymphoma that involves one or both eye sockets.
- Your doctors have seen measurable disease in the eye socket after biopsy, either by exam or imaging.
- You are able to get around and care for yourself (ECOG 0-3).
- You have not had radiation to the eye socket before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of a targeted drug (Orelabrutinib) and radiation therapy for adults newly diagnosed with a slow-growing lymphoma around the eye. The goal is to see if this approach works well and is safe for people who have not had treatment before.
This trial compares two treatments for a slow-growing eye lymphoma called MALT lymphoma: a targeted injection (rituximab) directly into the tumor versus low-dose radiation. The goal is to see which is safer and works better, while avoiding whole-body side effects.
This trial tests whether giving a lower dose of radiation than usual works well for people with slow-growing B-cell lymphomas. It aims to reduce side effects while still controlling the disease.
This study compares two treatments for a slow-growing eye lymphoma called MALT lymphoma. One uses a drug called rituximab injected directly into the tumor, and the other uses targeted radiation. The goal is to see which works better with fewer side effects.
This trial tests whether orbital (eye-socket) radiotherapy can improve active Graves’ orbitopathy, a condition that affects the eyes and eye muscles. It may help reduce eye inflammation and related symptoms if you meet the specific activity and severity criteria.
This trial tests whether a lower dose of radiation, guided by PET scans, is safe and effective for people with early-stage but unfavorable Hodgkin lymphoma. It aims to reduce side effects while keeping the treatment strong.
Hear when a new Orbital Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.